Literature DB >> 29914005

Targeted regulationof STAT3 by miR-29a in mediating Taxol resistance of nasopharyngeal carcinoma cell line CNE-1.

Jie Gao, Zhongjun Shao, Min Yan, Ting Fu, Lei Zhang, Yongping Yan.   

Abstract

STAT3 is an important molecule in Janus kinase (JAK) signal transducer and activator of transcription (STAT) signal pathway, and facilitates expression of various oncogenic genes such as Bcl-2, thus is correlated with tumor onset, progression and drug resistance. MiR-29a down-regulation is associated with the pathogenesis of nasopharyngeal carcinoma. Bioinformatics analysis demonstrated a complementary binding between miR-29a and 3'-UTR of STAT3. This study aims to investigate the role of miR-29a in regulating STAT3, as well as in Taxol resistance of nasopharyngeal carcinoma CNE-1 cells. Dual luciferase reporter gene assay showed a regulatory relationship between miR-29a and STAT3. Rhodamine 123 repository in CNE-1 and CNE1/Taxol drug resistant cells was measured together with the expression of miR-29a, STAT3, and p-STAT3. Flow cytometry was used to measure cell apoptosis and PCNA expression under Taxol treatment. CNE-1/Taxol cells were treated with miR-29a mimic and or si-STAT3, followed by measuring the expression of miR-29a, STAT3, and p-STAT3 and cell apoptosis. CCK-8 assay was performed to evaluate cell proliferation. MiR-29a inhibited STAT3 expression. Significantly lower Rhodamine 123 repository, miR-29a expression and apoptosis and higher expression of STAT3, p-STAT3 and PCNA were observed in CNE-2/ Taxol cells than those in CNE-1 cells. Transfection of miR-29a mimic and/or si-STAT3 decreased STAT3, p-STAT3 and PCNA expression, inhibited proliferation and promoted cell apoptosis. MiR-29a down-regulation is correlated with drug resistance of nasopharyngeal carcinoma cell line CNE-1 and MiR-29a up-regulation decreases Taxol resistance of nasopharyngeal carcinoma CNE-1 cells possibly via inhibiting STAT3 and Bcl-2 expression.

Entities:  

Keywords:  MiR-29a; STAT3; drug resistance; nasopharyngeal carcinoma; taxol

Mesh:

Substances:

Year:  2018        PMID: 29914005     DOI: 10.3233/CBM-170964

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN: 1574-0153            Impact factor:   4.388


  11 in total

1.  Tim-3 promotes cell aggressiveness and paclitaxel resistance through NF-κB/STAT3 signalling pathway in breast cancer cells.

Authors:  Yizi Cong; Yuxin Cui; Shiguang Zhu; Jianqiao Cao; Haidong Zou; Tracey A Martin; Guangdong Qiao; Wenguo Jiang; Zhigang Yu
Journal:  Chin J Cancer Res       Date:  2020-10-31       Impact factor: 5.087

2.  AZD4547 targets the FGFR/Akt/SOX2 axis to overcome paclitaxel resistance in head and neck cancer.

Authors:  Abdulmelik Aytatli; Neslisah Barlak; Fatma Sanli; Hasan Onur Caglar; Betul Gundogdu; Arzu Tatar; Michael Ittmann; Omer Faruk Karatas
Journal:  Cell Oncol (Dordr)       Date:  2021-11-27       Impact factor: 6.730

Review 3.  Mechanisms of cancer cell death induction by paclitaxel: an updated review.

Authors:  Shuang Zhao; Yufei Tang; Ruohan Wang; Masoud Najafi
Journal:  Apoptosis       Date:  2022-07-18       Impact factor: 5.561

4.  Traditional Chinese Medicine Xiaoai Jiedu Recipe Suppresses the Development of Hepatocellular Carcinoma via Regulating the microRNA-29a/Signal Transducer and Activator of Transcription 3 Axis.

Authors:  Yanfen Shi; Wuming Kong; Yanxu Lu; Yu Zheng
Journal:  Onco Targets Ther       Date:  2020-07-29       Impact factor: 4.147

5.  Improved Radiotherapy Sensitivity of Nasopharyngeal Carcinoma Cells by miR-29-3p Targeting COL1A1 3'-UTR.

Authors:  Ying Guo; Jianhua Zhai; Jing Zhang; Changbao Ni; Huifang Zhou
Journal:  Med Sci Monit       Date:  2019-04-29

6.  microRNA-29a functions as a tumor suppressor in nasopharyngeal carcinoma 5-8F cells through targeting VEGF.

Authors:  Qingyuan Shi; Jinhua Dai; Lizhen Huang
Journal:  Iran J Basic Med Sci       Date:  2019-05       Impact factor: 2.699

7.  Promoting functions of microRNA-29a/199B in neurological recovery in rats with spinal cord injury through inhibition of the RGMA/STAT3 axis.

Authors:  Weijie Yang; Ping Sun
Journal:  J Orthop Surg Res       Date:  2020-09-18       Impact factor: 2.359

8.  A novel three-microRNA signature for predicting survival in patients with nasopharyngeal carcinoma.

Authors:  Shan-Qiang Zhang; Jun Liu; Hai-Bin Chen; Wen-Jie Dai; Li-Qing Zhou; Chong-Wei Xie; Ji-Cheng Li
Journal:  J Dent Sci       Date:  2021-09-08       Impact factor: 2.080

9.  Long Noncoding RNA UCA1 Accelerates Nasopharyngeal Carcinoma Cell Progression By Modulating miR-124-3p/ITGB1 Axis.

Authors:  Chunxiu Liu; Hu Zhang; Hui Liu
Journal:  Onco Targets Ther       Date:  2019-10-11       Impact factor: 4.147

Review 10.  Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma.

Authors:  Yuanbo Kang; Weihan He; Caiping Ren; Jincheng Qiao; Qiuyong Guo; Jingyu Hu; Hongjuan Xu; Xingjun Jiang; Lei Wang
Journal:  Signal Transduct Target Ther       Date:  2020-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.